{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:26:01Z","timestamp":1793460361779,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd003497","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2005,10,19]],"date-time":"2005-10-19T00:00:00Z","timestamp":1129680000000}}],"reference-count":39,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003497.pub2","type":"journal-article","created":{"date-parts":[[2005,10,7]],"date-time":"2005-10-07T07:54:39Z","timestamp":1128671679000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Combined vitamin B6-magnesium treatment in autism spectrum disorder"],"prefix":"10.1002","volume":"2009","author":[{"given":"Chad","family":"Nye","sequence":"first","affiliation":[{"name":"University of Central Florida; UCF CARD Center; 12001 Science Dr. Suite 145 Orlando Florida USA FL 32826"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Brice","sequence":"additional","affiliation":[{"name":"University of Central Florida; Dept of Communicative Disorders; P. O. Box 162215 Orlando Florida USA 32816-2215"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,10,19]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD003497.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1023\/A:1025861522935","article-title":"High-dose pyridoxine and magnesium administration in children with autistic disorder: An absence of salutary effects in a double-blind, placebo-controlled study","volume":"27","author":"Findling","year":"1997","journal-title":"Journal of Autism and Developmental Disabilities"},{"key":"10.1002\/14651858.CD003497.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1017\/S0012162201232071","article-title":"Pyridoxine treatment in a subgroup of children with pervasive developmental disorders","volume":"44","author":"Kuriyama","year":"2002","journal-title":"Developmental Medicine & Child Neurology"},{"issue":"1","key":"10.1002\/14651858.CD003497.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF01066428","article-title":"Brief report: Lack of response in an autistic population to a low dose clinical trial of pyridoxine plus magnesium","volume":"23","author":"Tolbert","year":"1993","journal-title":"Journal of Autism and Developmental Disabilities"},{"issue":"5","key":"10.1002\/14651858.CD003497.pub2-BIB0004|cit4","first-page":"627","article-title":"Biological and clinical effects of oral magnesium and associated magnesium-vitamin B6 administration on certain disorders observed in infantile autism (author's transl)","volume":"35","author":"Barthelemy","year":"1980","journal-title":"Therapie"},{"key":"10.1002\/14651858.CD003497.pub2-BIB0005|cit5","first-page":"150","article-title":"Behavioral and biological effects of oral magnesium, vitamin B6, and combined magnesium-B6 administration in autistic children","volume":"2","author":"Barthelemey","year":"1981","journal-title":"Magnesium Bulletin"},{"issue":"5-6","key":"10.1002\/14651858.CD003497.pub2-BIB0006|cit6","first-page":"289","article-title":"Value of behavior scales and urinary homovanillic acid determinations in monitoring the combined treatment with vitamim B6 and magnesium of children displaying autistic behavior","volume":"31","author":"Barthelemy","year":"1983","journal-title":"Neuropsychiatrie de l Enfance et de l'Adolescence"},{"key":"10.1002\/14651858.CD003497.pub2-BIB0007|cit7","first-page":"101","article-title":"Marqueurs cliniques (items d'echelles de comportement), electrophysiologiques (potentials evoques conditionnes) et biochimiques (acide homovanillique urinaire) dans l'autisme de l'enfant","volume":"11","author":"Barthelemy","year":"1985","journal-title":"L'Encephale"},{"issue":"8","key":"10.1002\/14651858.CD003497.pub2-BIB0008|cit8","first-page":"308","article-title":"Experiences with pyrithioxin in brain-damaged children with autistic syndrome","volume":"17","author":"Bonish","year":"1968","journal-title":"Praxis der Kinderpsychologie und Kinderpsychiatrie."},{"issue":"6","key":"10.1002\/14651858.CD003497.pub2-BIB0009|cit9","first-page":"661","article-title":"Clinical and biochemical value of Magnesium + vitamin B6 combination in the treatment of residual autism in adults","volume":"39","author":"Jonas","year":"1984","journal-title":"Therapie"},{"issue":"12","key":"10.1002\/14651858.CD003497.pub2-BIB0010|cit10","first-page":"797","article-title":"L'acide homovanilique urinaire et ses modifications par ingestion de vitamine B6: Exploration fonctionnelle dans l'autisme de l'enfant? Rev. Neurol (Paris) 1978;134(12):797-801.Lelord G, Muh JP, Barthelemy C, Martineau J, Garreau J. Effects of pyridoxine and magnesium on autistic symptoms-initial observations","volume":"134","author":"Lelord","year":"1978","journal-title":"Rev. Neurol (Paris)"},{"issue":"2","key":"10.1002\/14651858.CD003497.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF01531686","article-title":"Effects of pyridoxine and magnesium on autistic symptoms-initial observations","volume":"11","author":"Lelord","year":"1981","journal-title":"Journal of Autism and Developmental Disabilities"},{"issue":"1-2","key":"10.1002\/14651858.CD003497.pub2-BIB0012|cit12","first-page":"27","article-title":"Clinical and biological effects of high doses of vitamin B6 and Magnesium on autistic children","volume":"4","author":"Lelord","year":"1982","journal-title":"Acta Vitaminologica et Enzymologica"},{"issue":"7","key":"10.1002\/14651858.CD003497.pub2-BIB0013|cit13","first-page":"627","article-title":"Effects of vitamin B6 on averaged evoked potentials in infantile autism","volume":"16","author":"Martineau","year":"1981","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD003497.pub2-BIB0014|cit14","first-page":"411","article-title":"Comparative effects of oral B6 Mg and Mg administration on evoked potentials conditioning in autistic children","volume-title":"Event-related potentials in children","author":"Martineau","year":"1982"},{"issue":"5","key":"10.1002\/14651858.CD003497.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0006-3223(85)90019-8","article-title":"Vitamin B6, magnesium, and combined B6-Mg: therapeutic effects in childhood autism","volume":"20","author":"Martineau","year":"1985","journal-title":"Biological Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD003497.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/BF02212198","article-title":"Brief Report: An open middle-term study of combined vitamin B6-Magnesium in a subgroup of autistic children selected on their sensitivity to this treatment","volume":"18","author":"Martineau","year":"1988","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"6","key":"10.1002\/14651858.CD003497.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1469-8749.1989.tb04067.x","article-title":"Electrophysiological effects of fenfluramine or combined vitamin B6 and magnesium on children with autistic behaviour","volume":"31","author":"Martineau","year":"1989","journal-title":"Developmental Medicine & Child Neurology"},{"issue":"5-6","key":"10.1002\/14651858.CD003497.pub2-BIB0018|cit18","first-page":"326","article-title":"CD4+ CD45RA+ T lymphocyte deficiency in autistic children: effect of a pyridoxine-magnesium treatment","volume":"5","author":"Menage","year":"1992","journal-title":"Brain Dysfunction"},{"issue":"4","key":"10.1002\/14651858.CD003497.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1176\/ajp.135.4.472","article-title":"The effect of high doses of Vitamin B6 on autistic children: a double-blind crossover study","volume":"135","author":"Rimland","year":"1978","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003497.pub2-BIB0020|cit20","volume-title":"Cochrane Reviewers' Handbook 4.2.2 (updated December 2003). In: The Cochrane Library, Issue 1, 2004","author":"Alderson","year":"2004"},{"issue":"5","key":"10.1002\/14651858.CD003497.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/070674377301800505","article-title":"Potentiation of therapeutic effects of nicotinic acid by pyridoxine in chronic schizophrenics","volume":"18","author":"Ananth","year":"1973","journal-title":"Canadian Psychiatric Association Journal"},{"key":"10.1002\/14651858.CD003497.pub2-BIB0022|cit22","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"issue":"567","key":"10.1002\/14651858.CD003497.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1192\/bjp.122.2.240","article-title":"Pyridoxine and schizophrenia","volume":"122","author":"Bucci","year":"1973","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003497.pub2-BIB0024|cit24","first-page":"1047","article-title":"Behavioral and cognitive measures used in psychopharamocologic studies of infantile autism","volume":"21","author":"Campbell","year":"1985","journal-title":"Psychopharamacology Bulletin"},{"key":"10.1002\/14651858.CD003497.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF02172092","article-title":"Domains of the Childhood Autism Rating Scale; Relevance for diagnosis and treatment","volume":"24","author":"DiLalla","year":"1994","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"7109","key":"10.1002\/14651858.CD003497.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003497.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1017\/S0033291799008508","article-title":"The epidemiology of autism: a review","volume":"29","author":"Fombonne","year":"1999","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD003497.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/jama.289.1.87","article-title":"The prevalence of autism","volume":"289","author":"Fombonne","year":"2003","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD003497.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0002-7138(09)60610-5","article-title":"A scale for rating symptoms of patients with the syndrome of autism in real life settings","volume":"25","author":"Freeman","year":"1986","journal-title":"Journal of the American Academy of Child Psychiatry"},{"key":"10.1002\/14651858.CD003497.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF00919127","article-title":"Normative data on revised Conners parent and teacher rating scales","volume":"6","author":"Goyette","year":"1978","journal-title":"Journal of Abnormal Child Psychology"},{"issue":"1","key":"10.1002\/14651858.CD003497.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1176\/ajp.127.1.89","article-title":"An evaluation of niacinamide in the treatment of childhood schizophrenia","volume":"127","author":"Greenberg","year":"1970","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003497.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/archpsyc.1983.04390010015002","article-title":"Obsessive-compulsive disorder: A double-blind trial of clomipramine and clorgyline","volume":"40","author":"Insel","year":"1983","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD003497.pub2-BIB0033|cit33","first-page":"839","article-title":"Clinical Global Impression Scale","volume":"21","author":"National Institutes of Mental Health","year":"1985","journal-title":"Psychopharamacology Bulletin"},{"key":"10.1002\/14651858.CD003497.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/1097-4679(198809)44:5<708::AID-JCLP2270440507>3.0.CO;2-T","article-title":"Behavioral assessment of psychopathology in children: Infantile autism","volume":"44","author":"Overall","year":"1988","journal-title":"Journal of Clinical Psychology"},{"issue":"5","key":"10.1002\/14651858.CD003497.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF02178295","article-title":"Efficacy of vitamin B6 and magnesium in the treatment of autism: A methodology review and summary of outcomes","volume":"25","author":"Pfeiffer","year":"1996","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1002\/14651858.CD003497.pub2-BIB0036|cit36","volume-title":"Infantile autism: The syndrome and its implications for neural theory of behavior","author":"Rimland","year":"1964"},{"key":"10.1002\/14651858.CD003497.pub2-BIB0037|cit37","article-title":"High-doseage levels of certain vitamins in the treatment of children with mental disorders","volume-title":"Orthomolecular psychiatry: treatment of schizophrenia","author":"Rimland","year":"1973"},{"key":"10.1002\/14651858.CD003497.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1056\/NEJM198308253090801","article-title":"Sensory neuropathy from pyridoxine abuse","volume":"309","author":"Schaumberg","year":"1983","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003497.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF02408436","article-title":"Toward objective classification of childhood autism: Childhood autism rating scale (CARS)","volume":"1","author":"Schopler","year":"1980","journal-title":"Journal of Autism and Developmental Disabilities"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD003497.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T07:32:54Z","timestamp":1762327974000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003497.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Developmental, Psychosocial and Learning Problems Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2005,10,19]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2009,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003497.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,19]]}}}